{"id":"NCT03296163","sponsor":"mAbxience Research S.L.","briefTitle":"A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","officialTitle":"A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-02-06","primaryCompletion":"2019-07-03","completion":"2020-02-27","firstPosted":"2017-09-28","resultsPosted":"2021-03-26","lastUpdate":"2021-04-26"},"enrollment":627,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Non-small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"MB02 (Bevacizumab Biosimilar Drug)","otherNames":["Bevacizumab"]},{"type":"DRUG","name":"EU-approved Avastin®","otherNames":["Bevacizumab"]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Taxol"]}],"arms":[{"label":"MB02 (Bevacizumab Biosimilar Drug)","type":"EXPERIMENTAL"},{"label":"EU-approved Avastin®","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multicenter, multinational, double-blind, 1:1 randomized, parallel-group, equivalence Phase 3 study to compare the efficacy and safety of MB02 plus chemotherapy (carboplatin and paclitaxel) versus Avastin® plus chemotherapy (carboplatin and paclitaxel) in subjects with Stage IIIB/IV non-squamous NSCLC","primaryOutcome":{"measure":"Objective Response Rate (ORR) at Week 18","timeFrame":"18 weeks from randomisation","effectByArm":[{"arm":"MB02 (Bevacizumab Biosimilar Drug)","deltaMin":40.3,"sd":null},{"arm":"EU-approved Avastin®","deltaMin":44.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":5},"locations":{"siteCount":118,"countries":["Brazil","Bulgaria","Chile","Georgia","Greece","Hungary","India","Lebanon","Malaysia","Mexico","Oman","Philippines","Russia","Serbia","Spain","Thailand","Turkey (Türkiye)","Ukraine"]},"refs":{"pmids":["33914256"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":311},"commonTop":["Alopecia","Anemia","Nausea","Thrombocytopenia","Neutropenia"]}}